Alliance Provides Potential Customers with Access to Lentiviral Vector Expertise and
cGMP Manufacturing Capabilities
Baltimore and Rockville, MD, December 6, 2005
Lentigen Corporation, a privately
Read More...
Industry and Academic Veterans Launch Operations for Lentiviral Technology
Baltimore, Maryland, December 2, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of res Read More...
Funding to Launch Breakthrough Delivery Technology for Biologics
Baltimore, MD, November 30, 2005
Lentigen Corporation, a privately held
biotechnology company focused on the manufacturing and development of lentiviral
vectors, announced that Read More...
Baltimore, MD, November 14, 2005
Lentigen Corporation, a privately owned biotechnology company focused on manufacturing and developing research and therapeutic grade lentiviral vectors, announced today the launch of the first website devoted to provid Read More...
BALTIMORE , MD (July 22, 2005)
Lentigen Corporation has joined the
techcenter@UMBC Incubator Program. Lentigen is a start-up company that
focuses on harnessing the power of Lentiviral vector ( LV ) gene delivery and
expression technology for a wide v Read More...
